A SUSTAINED RELEASE FORMULATION OF METHOTREXATE AS A DISEASE MODIFYING ANTIRHEUMATIC DRUG (DMARD) AND AN ANTI CANCER AGENT

• 收藏
• 分享

专利权人:

发明人:

GARCIA LOUIE DANIEL,GIBSON LOIS,LAMBERT WILLIAM,LI BENJAMIN,ZHU LIANGJIN

申请号：

IN2692/MUMNP/2012

公开号：

IN2012MN02692A

申请日:

2012.12.04

申请国别(地区):

IN

年份:

2014

代理人:

摘要：

Disclosed is are formulations comprising a multivesicular liposome and MTX the administration of which results in a C of MTX between 5% and 50% of the Cof an immediate release dosage form of MTX the duration of which lasts from about 1 to about 30 days. Also disclosed are methods of treating autoimmune diseases and cancer by administering these formulations of MTX.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/